CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma.
Adrenocortical tumors comprise frequent adenomas (ACA) and rare carcinomas (ACC). Human cytochrome P450 2W1 (CYP2W1) is highly expressed in some cancers holding the potential to activate certain drugs into tumor cytotoxins.To investigate the CYP2W1 expression in adrenal samples and its relationship...
Main Authors: | Cristina L Ronchi, Silviu Sbiera, Marco Volante, Sonja Steinhauer, Vanessa Scott-Wild, Barbara Altieri, Matthias Kroiss, Margarita Bala, Mauro Papotti, Timo Deutschbein, Massimo Terzolo, Martin Fassnacht, Bruno Allolio |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4140842?pdf=render |
Similar Items
-
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study
by: Barbara Altieri, et al.
Published: (2020-02-01) -
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells.
by: Antonina Germano, et al.
Published: (2018-01-01) -
Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?
by: Iuliu Sbiera, et al.
Published: (2021-04-01) -
Recovery of Adrenal Insufficiency Is Frequent After Adjuvant Mitotane Therapy in Patients with Adrenocortical Carcinoma
by: Jonathan Poirier, et al.
Published: (2020-03-01) -
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma
by: Antonina Germano, et al.
Published: (2020-04-01)